Journal of Alzheimers Disease & Parkinsonism
51ºÚÁϳԹÏÍø
Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 51ºÚÁϳԹÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
51ºÚÁϳԹÏÍø Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Citations : 4334
Indexed In
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Open J Gate
- Genamics JournalSeek
- Academic Keys
- JournalTOCs
- China National Knowledge Infrastructure (CNKI)
- Electronic Journals Library
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- SWB online catalog
- Virtual Library of Biology (vifabio)
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
Yolkin polypeptide complex isolated from hen egg yolk regulates BDNF production in PC12 cells via cAMP/CREB -dependent mechanism
12th International Conference on Alzheimer's Disease & Dementia
W Kazana, A Zambrowicz, J Siednienko and A Zabłocka
Hirszfeld Institute of Immunology and Experimental Therapy-Polish Academy of Sciences, PolandWrocław University of Environmental and Life Sciences, Poland
Posters & Accepted Abstracts: J Alzheimers Dis Parkinsonism
DOI:
Abstract
Background & Aim: Brain-derived neurotrophic factor (BDNF) supports neurons of the central nervous system (CNS) and is a key molecule in the maintenance of synaptic plasticity and memory storage in the hippocampus. However, changes in the level of BDNF mRNA or protein have been reported both in the CNS and in the blood of Alzheimer's disease (AD) patients, which indicates its potential role in the pathogenesis of AD. Yolkin, the polypeptide complex isolated from hen egg yolk was discovered as a fraction accompanying immunoglobulin IgY, which possesses neuroprotective activity and improves cognitive function of aged rats. We also demonstrated that yolkin stimulates both PC12 neuron-like cells and human whole blood cells to release BDNF in a dose- and time-dependent manner. However, the mechanism of yolkin action is not clear. The aim of the present study was to investigate the mechanism of yolkin action which leads to increased BDNF production by PC12 cells. Methods & Results: We have found that yolkin stimulates PC12 cells to release significant amounts of mature BDNF protein, when added at concentrations higher than 10 μg/ml in a time-dependent manner. This effect was connected with the impact of yolkin on activation of adenylate cyclase, resulting in the increase of cAMP concentration and upstream phosphorylation of cAMP response element-binding protein (CREB). Conclusion: Our study showed that the regulatory substance of natural origin, yolkin, is able to amplify neuroprotective mechanisms in the CNS and can be considered as a potential therapeutic agent in the treatment of neurodegenerative diseases.Biography
W Kazana is a second-year PhD student at the Hirszfeld Institute of Immunology and Experimental Therapy in Wrocław. She graduated in Biotechnology from Wrocław University of Science and Technology (MSc thesis awarded). Her research focuses on neuroprotective and immunoregulatory properties of yolkin, polypeptide complex isolated from hen egg yolk. She has already presented her preliminary results at Neuronus conference (poster) and symposium opening Biotechnology: Research and Industrial Applications conference (oral presentation) during this year. She is also one of the Co-Authors of an article presented in Neuropsychiatry, London.
E-mail: wioletta.kazana@iitd.pan.wroc.pl
